%A Li,Shun %A Wu,Bin %A Ling,Yun %A Guo,Mingquan %A Qin,Boyin %A Ren,Xiaonan %A Wang,Chao %A Yang,Hua %A Chen,Lixiang %A Liao,Yixin %A Liu,Yang %A Peng,Xiuhua %A Xu,Chunhua %A Wang,Zhenyan %A Shen,Yinzhong %A Chen,Jun %A Liu,Li %A Niu,Bowen %A Zhu,Mengmin %A Liu,Lingling %A Li,Feng %A Zhu,Tongyu %A Zhu,Zhaoqin %A Zhou,Xiaohui %A Lu,Hongzhou %D 2021 %J Frontiers in Immunology %C %F %G English %K SARS-CoV-2,COVID-19,chromatin accessibility,transcriptome profiling,scATAC-seq,ScRNA-seq,T cells %Q %R 10.3389/fimmu.2021.625881 %W %L %M %P %7 %8 2021-February-24 %9 Original Research %# %! scATAC-seq and scRNA-seq analysis of T cells from COVID-19 patients %* %< %T Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 Patients %U https://www.frontiersin.org/articles/10.3389/fimmu.2021.625881 %V 12 %0 JOURNAL ARTICLE %@ 1664-3224 %X T cells play a critical role in coronavirus diseases. How they do so in COVID-19 may be revealed by analyzing the epigenetic chromatin accessibility of cis- and trans-regulatory elements and creating transcriptomic immune profiles. We performed single-cell assay for transposase-accessible chromatin (scATAC) and single-cell RNA (scRNA) sequencing (seq) on the peripheral blood mononuclear cells (PBMCs) of severely ill/critical patients (SCPs) infected with COVID-19, moderate patients (MPs), and healthy volunteer controls (HCs). About 76,570 and 107,862 single cells were used, respectively, for analyzing the characteristics of chromatin accessibility and transcriptomic immune profiles by the application of scATAC-seq (nine cases) and scRNA-seq (15 cases). The scATAC-seq detected 28,535 different peaks in the three groups; among these peaks, 41.6 and 10.7% were located in the promoter and enhancer regions, respectively. Compared to HCs, among the peak-located genes in the total T cells and its subsets, CD4+ T and CD8+ T cells, from SCPs and MPs were enriched with inflammatory pathways, such as mitogen-activated protein kinase (MAPK) signaling pathway and tumor necrosis factor (TNF) signaling pathway. The motifs of TBX21 were less accessible in the CD4+ T cells of SCPs compared with those in MPs. Furthermore, the scRNA-seq showed that the proportion of T cells, especially the CD4+ T cells, was decreased in SCPs and MPs compared with those in HCs. Transcriptomic results revealed that histone-related genes, and inflammatory genes, such as NFKBIA, S100A9, and PIK3R1, were highly expressed in the total T cells, CD4+ T and CD8+ T cells, both in the cases of SCPs and MPs. In the CD4+ T cells, decreased T helper-1 (Th1) cells were observed in SCPs and MPs. In the CD8+T cells, activation markers, such as CD69 and HLA class II genes (HLA-DRA, HLA-DRB1, and HLA-DRB5), were significantly upregulated in SCPs. An integrated analysis of the data from scATAC-seq and scRNA-seq showed some consistency between the approaches. Cumulatively, we have generated a landscape of chromatin epigenetic status and transcriptomic immune profiles of T cells in patients with COVID-19. This has provided a deeper dissection of the characteristics of the T cells involved at a higher resolution than from previously obtained data merely by the scRNA-seq analysis. Our data led us to suggest that the T-cell inflammatory states accompanied with defective functions in the CD4+ T cells of SCPs may be the key factors for determining the pathogenesis of and recovery from COVID-19.